Clinical pharmacodynamics analysis of personalized peptide therapeutic tumor vaccinesHE Qing, GAO Hua, WANG Jun-zhi1729-1737
Quality study of recombinant anti-interleukin-23 monoclonal antibodiesFU Zhi-hao, WU Gang, LI Meng, CUI Yong-fei, WANG Lan1738-1745
The quality issues in quality review for stem cell clinical research and its primary analysisZHANG Ke-hua, NA Tao, HAN Xiao-yan, WU Ting-ting, ZHANG Li-xia, JIA Chun-cui, YUAN Xiang-he, FENG Jian-ping, XIANG Nan, MENG Shu-fang1746-1751
Research and development progress of SARS-CoV-2 neutralizing antibodyYUE Xin, PAN Yong-bing, YANG Xiao-ming1752-1758
Recent progress in the research and development of CAR-T productsLIU Qian-yong, Mark GILBERT, LI Yi-ping1759-1767
Recent progress in clinical research of mRNA technologiesYI Ying-lei, XU Cong-cong, YAO Wei-guo, ZHANG Yu-jian, ZHANG Ai-hua, LI Hang-wen1768-1774
The feasibility analysis of SARS-CoV-2 neutralizing antibody colloidal gold test card for the detection of neutralizing antibodies in different populationsZHOU Zhi-jun, PENG Yan, JI De-ming, ZHANG Yong, FENG Lu, LI Tao-jing, XIA Dong-mei, HU Yong, LI Ce-sheng1775-1782
Pharmacodynamics study of human rabies immunoglobulinLIU Bo, YANG Shuo, QIN Ting-ting, ZHANG Cong-ming, LU Ting-ting, LI Xiao-jiao, ZHANG Hang, YANG Li-ming, WU Zhi-qiang, SUN Yong1783-1786
Development and application of a sandwich ELISA method for detection of N protein in SARS-CoV-2 inactivated vaccineZHAO Yu-xiu, YING Zhi-fang, SONG Yan-li, LI Ai-ling, GUO Yan-cen, DONG Yuan, LI Yan, WANG Hui1787-1793
Discussion on the safety of blood products during the COVID-19 pandemicTIAN Bo-kai, ZHANG Hua1794-1800